Patents by Inventor Maurizio Caserini

Maurizio Caserini has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of pidotimod to treat irritable bowel syndrome
    Patent number: 9446027
    Abstract: The present invention is directed to the use of pidotimod, or a physiologically acceptable salt thereof, to treat irritable bowel syndrome. For the treatment of the present invention, pidotimod, or a physiologically acceptable salt thereof, may be administered either by oral route or rectally.
    Type: Grant
    Filed: April 5, 2013
    Date of Patent: September 20, 2016
    Assignee: POLICHEM SA
    Inventors: Federico Mailland, Francesco Scarci, Maurizio Caserini
  • Use of pidotimod to treat irritable bowel syndrome
    Patent number: 9408833
    Abstract: The present invention is directed to the use of pidotimod, or a physiologically acceptable salt thereof, to treat irritable bowel syndrome. For the treatment of the present invention, pidotimod, or a physiologically acceptable salt thereof, may be administered either by oral route or rectally.
    Type: Grant
    Filed: April 5, 2013
    Date of Patent: August 9, 2016
    Assignee: POLICHEM SA
    Inventors: Federico Mailland, Francesco Scarci, Maurizio Caserini
  • METHOD TO TREAT ONYCHOMYCOSIS BY HYDROXYPROPYL CHITOSAN
    Publication number: 20160213705
    Abstract: The present invention is directed to a method to treat onychomycosis by topically administering a composition which contains hydroxypropyl chitosan as the sole active ingredient and, in particular, by administering a nail topical composition consisting essentially of: a) hydroxypropyl chitosan, b) water, c) at least a lower alkanol.
    Type: Application
    Filed: September 8, 2014
    Publication date: July 28, 2016
    Applicant: POLICHEM S.A.
    Inventors: Federico Mailland, Maurizio Caserini, Daniela Ceriani
  • USE OF PIDOTIMOD TO TREAT INFLAMMATORY BOWEL DISEASE
    Publication number: 20160058739
    Abstract: The present invention is directed to the use of pidotimod, or a physiologically acceptable salt thereof, to treat inflammatory bowel disease. For the treatment of the present invention, pidotimod, or a physiologically acceptable salt thereof, may be administered either by oral route or rectally.
    Type: Application
    Filed: April 5, 2013
    Publication date: March 3, 2016
    Inventors: Federico Mailland, Francesco Scarci, Maurizio Caserini
  • USE OF PIDOTIMOD TO TREAT IRRITABLE BOWEL SYNDROME
    Publication number: 20160058740
    Abstract: The present invention is directed to the use of pidotimod, or a physiologically acceptable salt thereof, to treat irritable bowel syndrome. For the treatment of the present invention, pidotimod, or a physiologically acceptable salt thereof, may be administered either by oral route or rectally.
    Type: Application
    Filed: April 5, 2013
    Publication date: March 3, 2016
    Inventors: Federico Mailland, Francesco Scarci, Maurizio Caserini
  • USE OF PIDOTIMOD TO TREAT ATOPIC DERMATITIS
    Publication number: 20150352081
    Abstract: The present invention is directed to the use of pidotimod, or a physiologically acceptable salt thereof, to treat atopic dermatitis. For the treatment of the present invention, pidotimod, or a physiologically acceptable salt thereof, is preferably administered topically.
    Type: Application
    Filed: December 19, 2012
    Publication date: December 10, 2015
    Inventors: Federico Mailland, Maurizio Caserini
  • USE OF PIDOTIMOD TO TREAT PSORIASIS
    Publication number: 20150328191
    Abstract: The present invention is directed to the use of pidotimod, or a physiologically acceptable salt thereof, to treat psoriasis. For the treatment of the present invention, pidotimod, or a physiologically acceptable salt thereof, may be administered either systemically or topically.
    Type: Application
    Filed: December 19, 2012
    Publication date: November 19, 2015
    Inventors: Maurizio Caserini, Federico Mailland